Free Trial

Cantor Fitzgerald's Rating of Electra Therapeutics on 10/13/2026

On October 13, 2026, Cantor Fitzgerald updated its outlook on Electra Therapeutics (NASDAQ:ETRA) with the action "Initiated Coverage", setting a "Overweight" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Cantor Fitzgerald

DateCompanyAction
10/13/2026
Applied Materials, Inc. stock logo
AMAT
Applied Materials
Reiterated Rating
10/13/2026
CytomX Therapeutics, Inc. stock logo
CTMX
CytomX Therapeutics
Reiterated Rating
10/13/2026
Freshworks Inc. stock logo
FRSH
Freshworks
Reiterated Rating
10/12/2026
AIIR
AIR Global
Initiated Coverage
10/12/2026
MasTec, Inc. stock logo
MTZ
MasTec
Reiterated Rating
10/12/2026
Lucid Group, Inc. stock logo
LCID
Lucid Group
Reiterated Rating
More Ratings From Cantor Fitzgerald